PubRank

Andrew T Parsa

Author PubWeight™ 200.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011 6.32
2 Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 2004 5.85
3 Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol 2008 2.71
4 Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg 2010 2.42
5 Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg 2010 2.19
6 Modern surgical outcomes following surgery for sphenoid wing meningiomas. J Neurosurg 2013 2.16
7 Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2009 2.15
8 Complications of lumboperitoneal shunts. Neurosurgery 2007 2.07
9 Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy. Neuro Oncol 2012 2.04
10 Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res 2013 1.86
11 Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg 2010 1.74
12 Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg 2010 1.72
13 The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg 2010 1.67
14 Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg 2010 1.67
15 Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. J Neurosurg 2011 1.67
16 Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 2008 1.66
17 Cancer and the complement cascade. Mol Cancer Res 2010 1.64
18 Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg 2012 1.64
19 The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci 2009 1.62
20 Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg 2009 1.59
21 Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review. J Neurosurg Pediatr 2012 1.57
22 Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss. J Neurosurg 2010 1.55
23 Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011. J Neurosurg 2013 1.55
24 Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg 2011 1.54
25 Extent of resection and the long-term durability of vestibular schwannoma surgery. J Neurosurg 2011 1.53
26 Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article. J Neurosurg 2010 1.53
27 Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 2006 1.52
28 Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review. J Neurosurg Spine 2013 1.51
29 Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg 2015 1.48
30 Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma. J Neurosurg 2010 1.48
31 A prospective study of hearing preservation in untreated vestibular schwannomas. J Neurosurg 2010 1.46
32 What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients? J Neurosurg 2014 1.44
33 TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol 2009 1.43
34 Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg 2010 1.38
35 Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol 2012 1.38
36 Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer 2011 1.35
37 Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. J Immunother 2009 1.33
38 The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus 2011 1.33
39 Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. J Neurosurg 2009 1.32
40 Predictors of mortality following treatment of intracranial hemangiopericytoma. J Neurosurg 2010 1.28
41 Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology 2010 1.28
42 CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci 2010 1.26
43 Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol 2009 1.25
44 Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg 2005 1.25
45 Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. Neuro Oncol 2013 1.25
46 Changes in transcranial motor evoked potentials during intramedullary spinal cord tumor resection correlate with postoperative motor function. Neurosurgery 2005 1.24
47 Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein. Clin Cancer Res 2012 1.15
48 The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res 2010 1.14
49 Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery 2012 1.13
50 A systematic review of intracranial chondrosarcoma and survival. J Clin Neurosci 2009 1.13
51 A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg 2010 1.11
52 A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors. J Neurosurg 2010 1.07
53 Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. J Neurooncol 2009 1.06
54 Cranial chondrosarcoma and recurrence. Skull Base 2010 1.06
55 Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 2010 1.05
56 Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy. Neurosurg Clin N Am 2010 1.04
57 Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol 2014 1.04
58 Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 2010 1.03
59 Embolization of skull base meningiomas and feeding vessels arising from the internal carotid circulation. Neurosurgery 2011 1.03
60 Endoscopic reconstruction of skull base defects with the nasal septal flap. Skull Base 2008 1.03
61 Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer 2010 1.02
62 mTOR-independent translational control of the extrinsic cell death pathway by RalA. Mol Cell Biol 2006 1.01
63 Gross total resection improves overall survival in children with choroid plexus carcinoma. J Neurooncol 2013 0.99
64 Radiosurgery of glomus jugulare tumors: a meta-analysis. Int J Radiat Oncol Biol Phys 2011 0.99
65 Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci 2009 0.98
66 Current management of choroid plexus carcinomas. Neurosurg Rev 2013 0.98
67 The long-term postsurgical prognosis of patients with pineoblastoma. Cancer 2011 0.97
68 Pathologic and epidemiologic findings of intramedullary spinal cord tumors. Neurosurg Clin N Am 2006 0.97
69 Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol 2010 0.97
70 EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. J Clin Invest 2014 0.97
71 The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. J Neurosurg 2010 0.96
72 Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis. Neuro Oncol 2012 0.96
73 Tuberculoma of the central nervous system. J Clin Neurosci 2013 0.96
74 Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg 2010 0.96
75 Systematic review of protein biomarkers of invasive behavior in glioblastoma. Mol Neurobiol 2013 0.95
76 Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas. Neurosurgery 2006 0.95
77 Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro. Clin Immunol 2002 0.95
78 Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. J Neurosurg 2010 0.95
79 Fluctuating response of a cystic vestibular schwannoma to radiosurgery: case report. Neurosurgery 2008 0.94
80 Immunological considerations of modern animal models of malignant primary brain tumors. J Transl Med 2009 0.93
81 Lack of B7 expression, not human leukocyte antigen expression, facilitates immune evasion by human malignant gliomas. Neurosurgery 2007 0.93
82 Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics. J Neurosurg 2009 0.93
83 Clinical characteristics and diagnostic imaging of epidermoid tumors. J Clin Neurosci 2011 0.92
84 A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas. J Neurosurg Pediatr 2013 0.92
85 A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma. Childs Nerv Syst 2012 0.92
86 Management of recurrent intracranial hemangiopericytoma. J Clin Neurosci 2011 0.92
87 Immunocompetent murine models for the study of glioblastoma immunotherapy. J Transl Med 2014 0.92
88 A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res 2009 0.91
89 Radiosurgery for glomus jugulare: history and recent progress. Neurosurg Focus 2009 0.91
90 Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion. Neuroreport 2009 0.90
91 Prognosis by tumor location in adults with spinal ependymomas. J Neurosurg Spine 2013 0.90
92 The molecular biology and novel treatments of vestibular schwannomas. J Neurosurg 2011 0.90
93 A comprehensive analysis of intracranial chordoma and survival: a systematic review. Br J Neurosurg 2011 0.90
94 Clinical and surgical considerations for cerebellopontine angle meningiomas. J Clin Neurosci 2011 0.90
95 Modified paramedian transpedicular approach and spinal reconstruction for intradural tumors of the cervical and cervicothoracic spine: clinical experience. Spine (Phila Pa 1976) 2007 0.89
96 Clinical features and post-surgical outcome of patients with astroblastoma. J Clin Neurosci 2011 0.89
97 Preservation of facial nerve function after resection of vestibular schwannoma. Br J Neurosurg 2010 0.89
98 Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res 2010 0.89
99 Vaccine therapies for patients with glioblastoma. J Neurooncol 2014 0.88
100 Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells. PLoS One 2012 0.87
101 Radiobiology of vestibular schwannomas: mechanisms of radioresistance and potential targets for therapeutic sensitization. Neurosurg Focus 2009 0.87
102 Secondary gliosarcoma: a review of clinical features and pathological diagnosis. J Neurosurg 2010 0.87
103 Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma. J Neurooncol 2010 0.86
104 Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro Oncol 2012 0.86
105 Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide. Mol Cancer Ther 2006 0.86
106 Extended bifrontal craniotomy for midline anterior fossa meningiomas: minimization of retraction-related edema and surgical outcomes. Neurosurgery 2006 0.86
107 Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol 2009 0.86
108 Stereotactic radiosurgery for benign meningiomas. J Neurooncol 2011 0.86
109 Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma. J Neurooncol 2014 0.85
110 Intramedullary spinal cord metastasis: clinical management and surgical considerations. Neurosurg Clin N Am 2006 0.85
111 A critical evaluation of cystic features in primary glioblastoma as a prognostic factor for survival. J Neurosurg 2011 0.85
112 Early surgical intervention in adult patients with ganglioglioma is associated with improved clinical seizure outcomes. J Clin Neurosci 2010 0.85
113 Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults. J Neurosurg Pediatr 2014 0.85
114 Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease. Neuro Oncol 2012 0.84
115 Contemporary management of pineoblastoma. Neurosurg Clin N Am 2011 0.84
116 Impact of resident involvement in neurosurgery: an analysis of 8748 patients from the 2011 American College of Surgeons National Surgical Quality Improvement Program database. J Neurosurg 2015 0.84
117 Immunotherapy for glioma: promises and challenges. Neurosurg Clin N Am 2012 0.84
118 Heat shock protein-peptide complex in the treatment of glioblastoma. Expert Rev Vaccines 2011 0.83
119 Factors influencing overall survival rates for patients with pineocytoma. J Neurooncol 2010 0.83
120 Mapping clinical outcomes expectations to treatment decisions: an application to vestibular schwannoma management. Otol Neurotol 2010 0.83
121 The prognostic implications of Hyam's subtype for patients with Kadish stage C esthesioneuroblastoma. J Clin Neurosci 2012 0.83
122 Hearing preservation rates after microsurgical resection of vestibular schwannoma. J Clin Neurosci 2010 0.83
123 Intraoperative neuromonitoring techniques in the surgical management of acoustic neuromas. Neurosurg Focus 2012 0.83
124 Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme. Expert Rev Anticancer Ther 2006 0.82
125 Human glioma demonstrates cell line specific results with ATP-based chemiluminescent cellular proliferation assays. J Clin Neurosci 2010 0.82
126 Results with judicious modern neurosurgical management of parasagittal and falcine meningiomas. Clinical article. J Neurosurg 2010 0.82
127 Complement and the central nervous system: emerging roles in development, protection and regeneration. Immunol Cell Biol 2010 0.82
128 Giant thoracic schwannoma presenting with abrupt onset of abdominal pain: a case report. J Med Case Rep 2009 0.82
129 Heat shock protein vaccines against glioblastoma: from bench to bedside. J Neurooncol 2015 0.82
130 Contemporary management of pineocytoma. Neurosurg Clin N Am 2011 0.81
131 Anticonvulsant prophylaxis for brain tumor surgery: determining the current best available evidence. J Neurosurg 2014 0.81
132 Erosive cholesterol granuloma. Otol Neurotol 2013 0.81
133 Signaling pathways in cranial chondrosarcoma: potential molecular targets for directed chemotherapy. J Clin Neurosci 2011 0.81
134 Non-audiofacial morbidity after Gamma Knife surgery for vestibular schwannoma. Neurosurg Focus 2009 0.81
135 Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma. J Clin Neurosci 2010 0.81
136 Heat-shock protein vaccines as active immunotherapy against human gliomas. Expert Rev Anticancer Ther 2009 0.81
137 Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma. J Neurooncol 2009 0.80
138 Awake far lateral craniotomy for resection of foramen magnum meningioma in a patient with tenuous motor and somatosensory evoked potentials. J Clin Neurosci 2011 0.80
139 Association of morbidity with extent of resection and cavernous sinus invasion in sphenoid wing meningiomas. J Neurol Surg B Skull Base 2012 0.80
140 Mannose-binding lectin 2 gene and risk of adult glioma. PLoS One 2013 0.80
141 Stereotactic radiosurgery and interstitial brachytherapy for glial neoplasms. J Neurooncol 2004 0.80
142 Translational regulation of TRAIL sensitivity. Cell Cycle 2006 0.80
143 The relative patient benefit of gross total resection in adult choroid plexus papillomas. J Clin Neurosci 2013 0.80
144 A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma: clinical article. J Neurosurg 2013 0.80
145 CD97 is a multifunctional leukocyte receptor with distinct roles in human cancers (Review). Int J Oncol 2013 0.80
146 Skull base chondrosarcoma: evidence-based treatment paradigms. Neurosurg Clin N Am 2013 0.80
147 Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients. PLoS One 2013 0.80
148 Solitary fibrous tumor arising from Cranial Nerve VI in the prepontine cistern: case report and review of a tumor subpopulation mimicking schwannoma. Neurosurgery 2006 0.80
149 The molecular pathology of central neurocytomas. J Clin Neurosci 2010 0.80
150 Neuroanatomical correlation of the House-Brackmann grading system in the microsurgical treatment of vestibular schwannoma. Neurosurg Focus 2012 0.80
151 EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target. Neuroreport 2010 0.79
152 Pre-operative factors affecting resectability of giant intracranial meningiomas. Can J Neurol Sci 2009 0.79
153 Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma. J Neurooncol 2011 0.79
154 Monitoring immune responses after glioma vaccine immunotherapy. Neurosurg Clin N Am 2010 0.79
155 Complement anaphylatoxins as immune regulators in cancer. Cancer Med 2014 0.79
156 The next step: innovative molecular targeted therapies for treatment of intracranial chordoma patients. Neurosurgery 2011 0.79
157 Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy. World Neurosurg 2011 0.79
158 Implications of cystic features in vestibular schwannomas of patients undergoing microsurgical resection. Neurosurgery 2011 0.78
159 A case of enteroviral meningoencephalitis presenting as rapidly progressive dementia. Nat Clin Pract Neurol 2008 0.78
160 Postoperative seizures following the resection of convexity meningiomas: are prophylactic anticonvulsants indicated? Clinical article. J Neurosurg 2010 0.78
161 Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells. Neuro Oncol 2013 0.78
162 Fractionated radiotherapy for optic nerve sheath meningiomas. J Clin Neurosci 2012 0.78
163 Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities. Neurosurgery 2015 0.78
164 MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas. J Clin Neurosci 2012 0.78
165 Temporal fossa hemangiopericytoma: a case series. Otol Neurotol 2009 0.77
166 Histologic grade and extent of resection are associated with survival in pediatric spinal cord ependymomas. Childs Nerv Syst 2013 0.77
167 Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN. Laboratory investigation. J Neurosurg 2008 0.77
168 Heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial. Neuro Oncol 2014 0.77
169 Tumor control after surgery and radiotherapy for pineocytoma. J Neurosurg 2010 0.77
170 Development of a symptomatic intracranial meningioma in a male-to-female transsexual after initiation of hormone therapy. J Clin Neurosci 2010 0.77
171 A critical evaluation of vestibular schwannoma surgery for patients younger than 40 years of age. Neurosurgery 2010 0.77
172 Surgical outcomes in choroid plexus papillomas: an institutional experience. J Neurooncol 2013 0.77
173 A newly identified transcriptional network for mesenchymal transformation of brain tumors: potential targets for therapeutic intervention. World Neurosurg 2010 0.77
174 Reporting standard compliance in publications of vestibular schwannoma patients treated with microsurgery. Otol Neurotol 2012 0.77
175 Prognosis by tumor location for pediatric spinal cord ependymomas. J Neurosurg Pediatr 2012 0.77
176 Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients. Neurosurgery 2013 0.77
177 Intraventricular neurocytomas. Neurosurg Clin N Am 2003 0.77
178 Pathology of pineal parenchymal tumors. Neurosurg Clin N Am 2011 0.77
179 Endoscopic third ventriculostomy. J Clin Neurosci 2006 0.77
180 G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells. J Clin Neurosci 2013 0.77
181 Clinical characteristics and surgical outcomes of patients presenting with meningiomas arising predominantly from the floor of the middle fossa. Neurosurgery 2010 0.76
182 A spheroid weighted-axis converter of vestibular schwannoma size: maximum diameter and cisternal volume. Otolaryngol Head Neck Surg 2012 0.76
183 Evidence of ambiguous differentiation and mTOR pathway dysregulation in subependymal giant cell astrocytoma. Turk Patoloji Derg 2012 0.76
184 Genetics and molecular biology of intramedullary spinal cord tumors. Neurosurg Clin N Am 2006 0.76
185 PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma. Immunotherapy 2014 0.76
186 Disseminated progression of glioblastoma after treatment with bevacizumab. Clin Neurol Neurosurg 2013 0.76
187 Skull thickening, paranasal sinus expansion, and sella turcica shrinkage from chronic intracranial hypotension. J Neurosurg Pediatr 2013 0.76
188 The value of intraoperative facial nerve electromyography in predicting facial nerve function after vestibular schwannoma surgery. J Clin Neurosci 2010 0.75
189 The effect of the 2003 Consensus Reporting Standards on publications describing patients with vestibular schwannoma treated with stereotactic radiosurgery. J Clin Neurosci 2012 0.75
190 Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas. J Neurooncol 2014 0.75
191 Spinal ependymomas: benefits of extent of resection for different histological grades. J Clin Neurosci 2013 0.75
192 Sarcoidosis of the pineal gland: an unusual presentation of neurosarcoidosis. J Neurooncol 2008 0.75
193 Vaccine therapies in malignant glioma. Curr Neurol Neurosci Rep 2015 0.75
194 Post-radiation reactive changes in a single vertebral body mimicking metastatic pineoblastoma. J Neurosurg Pediatr 2009 0.75
195 Sarcoma arising as a distinct nodule within glioblastoma: a morphological and molecular perspective on gliosarcoma. J Neurooncol 2011 0.75
196 Surgical resection and adjuvant radiotherapy for a large pineal hemangiopericytoma. J Clin Neurosci 2010 0.75
197 Acoustic neuroma. Preface. Neurosurg Clin N Am 2008 0.75
198 Incidence, risk factors, and outcome of venous infarction after meningioma surgery in 705 patients. J Clin Neurosci 2011 0.75
199 Neuromonitoring during surgery for metastatic tumors to the spine: intraoperative interpretation and management strategies. Neurosurg Clin N Am 2004 0.75
200 Management of vestibular schwannoma: focus on vertigo. CNS Oncol 2013 0.75
201 Occipital ganglioglioma in an older adult. J Clin Neurosci 2010 0.75
202 Clinical management of intramedullary spinal ependymomas in adults. Neurosurg Clin N Am 2006 0.75
203 Multidisciplinary care of patients with brain tumors. Surg Oncol Clin N Am 2013 0.75
204 Falcine and parasagittal chondrosarcomas. J Clin Neurosci 2013 0.75
205 Non-audiofacial morbidity after Gamma Knife surgery for vestibular schwannoma. J Neurosurg 2013 0.75
206 850 Glioma Patients Segregate into Two Distinct Immunosuppresssive Phenotypes Based on PTEN Status: Implications for Immunotherapy. Neurosurgery 2005 0.75
207 Vision salvage after resection of a giant meningioma in a patient with a loss in light perception. J Neurosurg 2009 0.75
208 Heat shock proteins in glioblastomas. Neurosurg Clin N Am 2010 0.75
209 Posterior fossa mass with multiple cranial neuropathies. J Clin Neurosci 2011 0.75
210 Akt/PKB Activation Facilitates Immune Escape in Glioma Patients 908. Neurosurgery 2006 0.75